liquid biopsy

Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts

A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.

Monitoring ctDNA enables earlier detection, real-time assessment of treatment response, and more personalized strategies that improve patient outcomes across a range of tumor types.

Researchers develop sensitive blood-based diagnostics to detect tiny traces of cancer.